Y-Mabs Therapeutics Inc - YMAB - stock price prediction, stock price target, analyst ratings from 5 analysts

Y-Mabs Therapeutics Inc has a share price target of US$ 9, revenue growth forecast of -5.4%, and profit growth estimate of -9.5% for FY25, based on top 5 analyst calls.